Literature DB >> 2698176

VIP: molecular biology and neurobiological function.

I Gozes1, D E Brenneman.   

Abstract

In the mammalian brain, a major regulatory peptide is vasoactive intestinal peptide (VIP). This 28 amino acid peptide, originally isolated from the porcine duodenum, was later found in the central and peripheral nervous systems and in endocrine cells, where it exhibits neurotransmitter and hormonal roles. Increasing evidence points to VIP's importance as a mediator or a modulator of several basic functions. Thus, VIP is a major factor in brain activity, neuroendocrine functions, cardiac activity, respiration, digestion, and sexual potency. In view of this peptide's importance, the mechanisms controlling its production and the pathways regulating its functions have been reviewed. VIP is a member of a peptide family, including peptides such as glucagon, secretin, and growth hormone releasing hormone. These peptides may have evolved by exon duplication coupled with gene duplication. The human VIP gene contains seven exons, each encoding a distinct functional domain on the protein precursor or the mRNA. VIP gene transcripts are mainly found in neurons or neuron-related cells. VIP gene expression is regulated by neuronal and endocrine signals that contribute to its developmental control. VIP exerts its function via receptor-mediated systems, activating signal transduction pathways, including cAMP. It can act as a neurotransmitter, neuromodulator, and a secretagog. As a growth and developmental regulator, VIP may have a crucial effect as a neuronal survival factor. We shall proceed from the gene to its multiple functions.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2698176     DOI: 10.1007/BF02740606

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  271 in total

1.  Astrocytes from forebrain, cerebellum, and spinal cord differ in their responses to vasoactive intestinal peptide.

Authors:  A J Cholewinski; G P Wilkin
Journal:  J Neurochem       Date:  1988-11       Impact factor: 5.372

2.  Immunohistochemical study of neuropeptides in vagal and glossopharyngeal afferent neurons in the rat.

Authors:  C J Helke; K M Hill
Journal:  Neuroscience       Date:  1988-08       Impact factor: 3.590

3.  Parasympathetic innervation of cutaneous blood vessels by vasoactive intestinal polypeptide-immunoreactive and acetylcholinesterase-positive nerves: histochemical and experimental study on rat lower lip.

Authors:  A Kaji; H Shigematsu; K Fujita; T Maeda; S Watanabe
Journal:  Neuroscience       Date:  1988-04       Impact factor: 3.590

4.  Intestinal secretion: stimulation by peptides.

Authors:  G O Barbezat; M I Grossman
Journal:  Science       Date:  1971-10-22       Impact factor: 47.728

5.  Exon duplication and divergence in the human preproglucagon gene.

Authors:  G I Bell; R Sanchez-Pescador; P J Laybourn; R C Najarian
Journal:  Nature       Date:  1983 Jul 28-Aug 3       Impact factor: 49.962

6.  Sequential expression in the nervous system of c-myb and VIP genes, located in human chromosomal region 6q24.

Authors:  I Gozes; H Nakai; M Byers; R Avidor; Y Weinstein; Y Shani; T B Shows
Journal:  Somat Cell Mol Genet       Date:  1987-07

7.  Hypothalamic vasoactive intestinal peptide messenger ribonucleic acid is increased in lactating rats.

Authors:  I Gozes; Y Shani
Journal:  Endocrinology       Date:  1986-12       Impact factor: 4.736

8.  Stimulatory effect of vasoactive intestinal polypeptide on catecholamine secretion from isolated guinea pig adrenal chromaffin cells.

Authors:  M Misbahuddin; M Oka; A Nakanishi; K Morita
Journal:  Neurosci Lett       Date:  1988-10-05       Impact factor: 3.046

9.  Binding of a nuclear protein to the cyclic-AMP response element of the somatostatin gene.

Authors:  M R Montminy; L M Bilezikjian
Journal:  Nature       Date:  1987 Jul 9-15       Impact factor: 49.962

10.  Studies toward the biosynthesis of vasoactive intestinal peptide (VIP).

Authors:  I Gozes; M Bodner; H Shwartz; Y Shani; M Fridkin
Journal:  Peptides       Date:  1984 Mar-Apr       Impact factor: 3.750

View more
  48 in total

1.  VIP-PACAP 2010: my own perspective on modulation of cognitive and emotional behavior.

Authors:  Illana Gozes
Journal:  J Mol Neurosci       Date:  2010-11       Impact factor: 3.444

Review 2.  Pharmacology and functions of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide: IUPHAR review 1.

Authors:  Anthony J Harmar; Jan Fahrenkrug; Illana Gozes; Marc Laburthe; Victor May; Joseph R Pisegna; David Vaudry; Hubert Vaudry; James A Waschek; Sami I Said
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

3.  Intestinotrophic glucagon-like peptide-2 (GLP-2) activates intestinal gene expression and growth factor-dependent pathways independent of the vasoactive intestinal peptide gene in mice.

Authors:  Bernardo Yusta; Dianne Holland; James A Waschek; Daniel J Drucker
Journal:  Endocrinology       Date:  2012-04-24       Impact factor: 4.736

4.  Microarray analyses of pituitary adenylate cyclase activating polypeptide (PACAP)-regulated gene targets in sympathetic neurons.

Authors:  Karen M Braas; Kristin C Schutz; Jeffrey P Bond; Margaret A Vizzard; Beatrice M Girard; Victor May
Journal:  Peptides       Date:  2007-04-19       Impact factor: 3.750

5.  VIP, from gene to behavior and back: summarizing my 25 years of research.

Authors:  Illana Gozes
Journal:  J Mol Neurosci       Date:  2008-07-08       Impact factor: 3.444

6.  Excitatory actions of peptide histidine isoleucine on thalamic relay neurons.

Authors:  Sang-Hun Lee; Charles L Cox
Journal:  Neuropharmacology       Date:  2008-08-30       Impact factor: 5.250

7.  A femtomolar-acting neuroprotective peptide.

Authors:  D E Brenneman; I Gozes
Journal:  J Clin Invest       Date:  1996-05-15       Impact factor: 14.808

8.  Learning and sexual deficiencies in transgenic mice carrying a chimeric vasoactive intestinal peptide gene.

Authors:  I Gozes; J Glowa; D E Brenneman; S K McCune; E Lee; H Westphal
Journal:  J Mol Neurosci       Date:  1993       Impact factor: 3.444

9.  Study of NO and VIP as non-adrenergic non-cholinergic neurotransmitters in the pig gastric fundus.

Authors:  R A Lefebvre; G J Smits; J P Timmermans
Journal:  Br J Pharmacol       Date:  1995-10       Impact factor: 8.739

10.  A fatty neuropeptide. Potential drug for noninvasive impotence treatment in a rat model.

Authors:  I Gozes; M Fridkin
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.